Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in IHE
35.3%
% of IHE's 34 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.2% | 23.4% | 12.2% |
|
JOHNSON & JOHNSON | 6.6% | 22.3% | 6.6% |
|
MERCK & CO. INC. | 6.2% | 4.8% | 4.8% |
|
PFIZER INC | 4.5% | 4.6% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 4.5% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to IHE
 |
NOVO-NORDISK A/S-SPONS ADR | 9.5% |
|
ABBVIE INC | 5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% |
 |
NOVARTIS AG-ADR | 4.8% |
|
AMERISOURCEBERGEN CORP | 4.7% |
|
MCKESSON CORP | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.9% |
PPH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -15.7% |
|
ELI LILLY & CO | -11.2% |
|
ROYALTY PHARMA PLC CLASS A | -4.6% |
|
CATALENT INC | -3.2% |
|
VIATRIS, INC. | -2.6% |
|
INTRA-CELLULAR THERAPIES INC | -2.5% |
|
ELANCO ANIMAL HEALTH, INC. | -2.2% |
 |
JAZZ PHARMACEUTICALS PLC | -1.9% |
|
PRESTIGE BRANDS HOLDINGS INC | -1.4% |
|
ORGANON & CO. | -1.3% |